Two new studies affirm the potential for a healthy lifestyle to reduce the risk of age-related dementia and cognitive decline. The research particularly suggests lifestyle factors can counteract genetic predispositions for Alzheimer’s disease.
Continue Reading
A rigorous animal study has demonstrated how the misfolded proteins thought to cause Parkinson’s disease may originate in the gut, and travel up to the brain via the vagus nerve. This research builds on evidence pointing to a gut-brain connection in the disease and hints at new treatment pathways.
Continue Reading
In the largest general population study ever conducted investigating the association between atrial fibrillation and dementia, Korean researchers have concluded there is a significant link between the common heart condition and the onset of neurodegenerative disease.
Continue Reading
New research from Johns Hopkins Medicine is suggesting neurodegenerative disease can be just as prevalent in individuals with higher education but a greater cognitive reserve can temporarily mitigate the impact of Alzheimer’s pathology in one’s senior years.
Continue Reading
An intriguing new study has described a mechanism by which virus particles can interact with proteins in biological fluids and become more infectious, while also accelerating the formation of plaques often associated with neurodegenerative diseases such as Alzheimer’s.
Continue Reading
An exciting new study from the University of Cambridge is demonstrating how a novel virtual reality navigation test can better predict which patients are in the early stages of Alzheimer's disease compared to other currently used "gold standard" cognitive tests.
Continue Reading
New research from Johns Hopkins University has identified a variety of biomarkers that can be used to predict the onset of Alzheimer’s years before symptoms appear. The study presents nine measures that can signal the onset of the disease up to 30 years before cognitive decline becomes apparent.
Continue Reading
Scientists in Germany are reporting successful results from the first phase of human clinical testing of a new Alzheimer’s drug. Following promising animal experiments the drug has initially now proved safe in human subjects and will soon move into Phase II clinical trials testing efficacy.
Continue Reading
Since 2016, a research team has been exploring the strange hypothesis that external exposure to light flickering at 40 Hz can reverse the neurodegeneration associated with Alzheimer's disease. A new study has now homed in on exactly how, on a cellular level, this light treatment could be working.
Continue Reading
A new two-step diagnostic process is claiming to confidently detect Alzheimer's disease nearly a decade before clinical symptoms appear. It's hoped that the method will improve the results of clinical trials by helping better identify patients at the earliest stages of the disease.
Continue Reading
See the stories that matter in your inbox every morning